Gadolinium Based Contrast Agents and NSF

By  

Current Rheumatology Reviews, Vol. 6, Iss. 3, 2010-08 ,pp. : 189-192

Bentham Science Publishers

Access to resources Recommend Favorite

Stability of linear and macrocyclic gadolinium based contrast agents

By Schmitt-Willich H  

British Journal of Radiology, Vol. 80, Iss. 955, 2007-07 ,pp. : 581-582

British Institute of Radiology

Access to resources Recommend Favorite

Interference of gadolinium-based contrast agents with the measurement of serum creatinine by the Jaffe reaction

By Haylor J   Vickers M E   Morcos S K  

British Journal of Radiology, Vol. 82, Iss. 977, 2009-05 ,pp. : 438-439

British Institute of Radiology

Access to resources Recommend Favorite

S K Morcos. Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? (Br J Radiol 2007;80:73–6)

By  

British Journal of Radiology, Vol. 80, Iss. 955, 2007-07 ,pp. : 586-586

British Institute of Radiology

Access to resources Recommend Favorite

Detection of Coronary Stenoses with Contrast Enhanced, Three-Dimensional Free Breathing Coronary MR Angiography Using the Gadolinium-Based Intravascular Contrast Agent Gadocoletic Acid (B-22956)

By Paetsch Ingo   Jahnke Cosima   Barkhausen Joerg   Spuentrup Elmar   Cavagna Friedrich   Schnackenburg Bernhard   Huber Michael   Stuber Matthias   Fleck Eckart   Nagel Eike  

Journal of Cardiovascular Magnetic Resonance, Vol. 8, Iss. 3, 2006-07 ,pp. : 509-516

Informa Healthcare

Access to resources Recommend Favorite